# FDA Inspection 1061620 - Schmidt, Richard Joseph MD Inc - July 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/schmidt-richard-joseph-md-inc/a19cd6bf-a328-4778-9a96-b927b3a21640
Source feed: FDA_Inspections

> FDA Inspection 1061620 for Schmidt, Richard Joseph MD Inc on July 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061620
- Company Name: Schmidt, Richard Joseph MD Inc
- Inspection Date: 2018-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262728 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/schmidt-richard-joseph-md-inc/0f0e1c83-9344-4a3a-808c-93daa6fdd34f)
- [FDA Inspection 1061620 - 2018-07-20](https://www.keypedia.com/records/fda_inspections/schmidt-richard-joseph-md-inc/ebfb68e4-416d-4665-9b3f-842b779ad8c1)
- [FDA Inspection 954424 - 2016-01-12](https://www.keypedia.com/records/fda_inspections/schmidt-richard-joseph-md-inc/3f2cbbd3-fc6a-463d-9661-bc503557723f)
- [FDA Inspection 826737 - 2013-04-08](https://www.keypedia.com/records/fda_inspections/schmidt-richard-joseph-md-inc/00c6a875-3a0a-4374-99d3-180680e7c5e0)

Company: https://www.keypedia.com/companies/schmidt-richard-joseph-md-inc/34543ee4-9515-4ddb-93e6-2572677184ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d